(Q73089301)
Statements
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer (English)
P M Dodd
J A McCaffrey
M Mazumdar
H Scher
G Higgins
M G Boyle
H Herr